Will Atea Pharmaceuticals Inc (AVIR) Stay at the Bottom of the Healthcare Sector?

Atea Pharmaceuticals Inc (AVIR) is near the bottom in its sector according to InvestorsObserver. AVIR gets an overall rating of 1. That means it scores higher than 1% of stocks. Atea Pharmaceuticals Inc gets a 17 rank in the Healthcare sector. Healthcare is number 8 out of 11 sectors.

AVIR has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on AVIR!

See Full AVIR Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 1 means the stock is more attractive than 1 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Atea Pharmaceuticals Inc Stock Today?

Atea Pharmaceuticals Inc (AVIR) stock is down -1.37% while the S&P 500 has risen 0.02% as of 11:47 AM on Tuesday, Dec 28. AVIR is lower by -$0.13 from the previous closing price of $9.43 on volume of 286,737 shares. Over the past year the S&P 500 is up 28.29% while AVIR is lower by -76.21%. AVIR earned $0.27 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 34.15. Click Here to get the full Stock Report for Atea Pharmaceuticals Inc stock.